研究文章
基因表达差异预测默克尔细胞癌患者的治疗效果
|
| 功能 |
预后良好 |
温和的预后 |
预后不良 |
总 |
|
(35%) |
(18%) |
(47%) |
|
|
| 性别 |
|
|
|
|
| 男性 |
3 (50%) |
2 (67%) |
4 (50%) |
9 (53%) |
| 女 |
3 (50%) |
1 (33%) |
4 (50%) |
8 (47%) |
| 年龄、年:值,范围 |
71.7 (54 - 82) |
78.7 (71 - 84) |
68.8 (44 - 83) |
|
| 位置 |
|
|
|
|
| 头部和颈部 |
3 (50%) |
1 (33%) |
2 (25%) |
6 (35%) |
| 上肢 |
2 (33%) |
1 (33%) |
2 (25%) |
5 (30%) |
| 下肢 |
1 (17%) |
0 (0%) |
3 (37.5%) |
4 (23%) |
| 躯干 |
0 (0%) |
1 (33%) |
1 (12.5%) |
2 (12%) |
| 与舞台上的诊断 |
|
|
|
|
| (我) |
2 (33%) |
1 (33%) |
0 (0%) |
3 (18%) |
| (2) |
3 (50%) |
2 (67%) |
5 (62.5%) |
10 (59%) |
| (3) |
1 (17%) |
0 (0%) |
3 (37.5%) |
4 (23%) |
|
|
